PR Newswire (press release) Carol Lou , General Manager of Clontech Laboratories, Inc., comments: "Clontech has already pushed the limits of RNA-Seq down to the single cell level with our SMARTer Ultra Low RNA Kit for Illumina® Sequencing. Today, we are expanding the applications ...
PR.com (press release) ... with EuroFlow™ Flow Cytometry Reagents and Infinicyt™ Analytical Software from. Salem, NH, April 30, 2013 --(PR.com)-- On April 30, 2013 ALPCO will begin offering specialized panels of flow cytometry reagents from Cytognos S.L., a supporting ... and more »
Wall Street Journal (press release) BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents . The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug ... and more »
Sacramento Bee BioLife's addressable portion of the market is the demand for reagents used to store, ship and freeze source material and manufactured doses of cell-based products and therapies. About BioLife ... This is a general interest news site. Sometimes, there ... and more »
ShareCast Speaking at its annual general meeting, the company unveiled Octavio Alvídrez as its new Chief Executive Officer, who Chairman Alberto Baillères described as "an experience and effective leader". In his address to investors, Baillères said the group ... and more »
Mideast Time ... technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general ... and more »
Sacramento Bee ... Science Center in Northampton, MA. In cooperation with New England Biolabs (NEB), a leader in the research and development of reagents for the life sciences, Smith College invites interested parties to learn molecular biology in this intensive ... and more »
Wall Street Journal (press release) We view all of our bioprocessing products as well positioned to benefit from the expected continued growth in demand worldwide for monoclonal antibodies and other biologic drugs," said Walter C. Herlihy, Ph.D., President and CEO of Repligen. "During ... and more »
